At its J.P. Morgan Conference 2026 presentation, Qiagen NV alluded to positive full-year results for 2025 and expressed that ...
GE HealthCare CEO Peter Arduini has highlighted the company’s disciplined approach to M&A in order to “fill gaps and add tuck ...
Clinical expectations in minimally invasive interventions is rising, making collaboration in the medical value chain ...
Medtronic CEO Geoff Martha has emphasised the strong interest levels and market potential for its Altaviva device for urge ...
Boston Scientific has acquired Valencia Technologies in a move to advance its urology and pelvic health portfolio with an ...
Waters Corporation is repositioning its growth profile through the acquisition of Becton Dickinson’s (BD) biosciences and ...
GE HealthCare’s focus is on connecting equipment, software, and consumables into care pathways, and simplifying its operating ...
Medtronic has outlined both its current market position and ambitious future at the ongoing J.P. Morgan Healthcare Conference ...
At the ongoing J.P. Morgan Healthcare Conference, Inspire Medical Systems boasted a five-year revenue set to grow at a CAGR ...
Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results